SML2627
Connexin43 mimetic peptide 5 trifluoroacetate salt
≥95% (HPLC)
同義詞:
Peptide 5 trifluoroacetate salt, VDCFLSRPTEKT trifluoroacetate salt, Val-Asp-Cys-Phe-Leu-Ser-Arg-Pro-Thr-Glu-Lys-Thr trifluoroacetate salt
登入查看組織和合約定價
全部照片(1)
About This Item
經驗公式（希爾表示法）:
C60H98N16O20S · xC2HF3O2
CAS號碼:
分子量：:
1395.58 (free base basis)
分類程式碼代碼:
12352200
NACRES:
NA.77
推薦產品
化驗
≥95% (HPLC)
形狀
lyophilized powder
顏色
white to beige
儲存溫度
−20°C
生化／生理作用
Connexin43 mimetic peptide 5 is a blocker of connexin43 hemichannels that inhibits gap junction channels following CNS injury. Peptide 5 was designed to bind to extracellular regions of the connexin43 protein.
blocker of connexin43 hemichannels that inhibits gap junction channels following CNS injury
儲存類別代碼
13 - Non Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
Yeri Kim et al.
Biochimica et biophysica acta. General subjects, 1861(2), 68-78 (2016-11-07)
Non-selective Connexin43 hemichannels contribute to secondary lesion spread. The hemichannel blocking peptidomimetic Peptide5, derived from the second extracellular loop of the human Connexin43 protein, prevents lesion spread and reduces vascular permeability in preclinical models of central nervous system injury. The
Yilin Mao et al.
Experimental brain research, 235(10), 3033-3048 (2017-07-21)
Systemic administration of a Connexin43 mimetic peptide, Peptide5, has been shown to reduce secondary tissue damage and improve functional recovery after spinal cord injury (SCI). This study investigated safety measures and potential off-target effects of Peptide5 systemic administration. Rats were
Helen V Danesh-Meyer et al.
Brain : a journal of neurology, 135(Pt 2), 506-520 (2012-02-22)
Connexin43 gap junction protein is expressed in astrocytes and the vascular endothelium in the central nervous system. It is upregulated following central nervous system injury and is recognized as playing an important role in modulating the extent of damage. Studies
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務